NDC 45963-615 – Topotecan hydrochloride
Topotecan Hydrochloride 4 mg/4mL · Injection, Powder, Lyophilized, For Solution · Intravenous
Product NDC45963-615
Product details
- Brand name
- Topotecan hydrochloride
- Generic name
- Topotecan hydrochloride
- Labeler
- Actavis Pharma, Inc.
- Dosage form
- Injection, Powder, Lyophilized, For Solution
- Route
- Intravenous
- Marketing category
- ANDA · ANDA090620
- Marketed since
- January 5, 2015
- Listing expires
- December 31, 2026
- Pharmacologic class
- Topoisomerase Inhibitor
Active ingredients
- Topotecan Hydrochloride 4 mg/4mL
Uses, dosage, side effects and warnings for Topotecan hydrochloride →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 45963-615-56 | 1 VIAL in 1 CARTON (45963-615-56) / 4 mL in 1 VIAL | Jan 5, 2015 |